Page 6 - NATIONAL INSTITUTES OF HEALTH (NIH) GUIDELINES FOR CONDUCTING RESEARCH IN MINISTRY OF HEALTH (MOH) INSTITUTIONS & FACILITIES 3RD EDITION 2021

8. MOH Research Grant (MRG) 19
8.1. Introduction 19

8.2. Mode of Application 19

8.3. Criteria for Application 19
8.4. MRG Review Panel 19

8.5. Priority in Research Evaluation 19
8.6. Result Notification in the MRG Application 20

8.7. Responsibility of Principal Investigator (PI) 20
8.8. Funding Scope 20

8.9. Amendment to Grant Allocation 21

8.10. Implementation and Research Conduct 21
8.11. Research Monitoring 21

8.12. Extension of Research 22
8.13. Termination of Grant 22

9. Collaborative Research 23
9.1. Memorandum of Understanding (MoU), Memorandum of Agreement 23
(MoA), and Research Agreement (RA)

9.2. Authorship 24
10. Publication and Presentation 25

10.1. Requirement for Publication and Presentation Submission 25
10.2. Processing of Publication and Presentation Submission 25

11. Special Regulatory Requirement(s) 27

11.1. National Pharmaceutical Regulatory Authority (NPRA) – Clinical Trial 27
Research

11.2. CKAPS (Cawangan Kawalan Amalan Perubatan Swasta) – Research 27
Involving Private Facilities

11.3. Medical Device Authority (MDA) – Research Involving Medical Devices 27
11.4. Human Tissue and Biological Samples of Import or Export License 27

11.5. Biosafety Act 2007, Act 678 and Biosafety Regulations 2010 - Research 27
Involving Modern Biotechnology and LMOs

iv NIH Guidelines for Conducting Research in MOH, 2021